Literature DB >> 6131363

Discriminative effects of ethylketazocine in the rat: stereospecificity and antagonism by naloxone.

S Herling, H E Shannon.   

Abstract

Male F344 rats were trained to discriminate between saline and d,l-ethylketazocine (EKC) in a two-choice discrete-trial avoidance task and tested with the l- and d-isomers of EKC, cyclazocine, and SKF-10,047. The effectiveness of naloxone in antagonizing the discriminative effects of d,l-EKC was also determined. Each of the l-isomers tested produced dose-related stimulus control of behavior similar to that produced by d,l-EKC. l-EKC was the most potent isomer tested, being approximately twice as potent as d,l-EKC. In contrast, d-EKC was completely devoid of activity at 300-fold higher doses. l-Cyclazocine and l-SKF-10,047 were approximately 4- and 30-fold less potent, respectively, than d,l-EKC. Although both d-cyclazocine and d-SKF-10,047 produced some drug-appropriate responding, both compounds were less potent and less efficacious than their respective l-isomers and both were significantly less efficacious than d,l-EKC. Increasing doses of naloxone (0.1 - 1.0 mg/kg) produced parallel shifts to the right in the d,l-EKC dose-effect curve. These results suggest that the discriminative effects of EKC are mediated by a stereospecific naloxone-sensitive receptor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6131363     DOI: 10.1016/0024-3205(82)90159-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.

Authors:  K W Locke; B Gorney; M Cornfeldt; S Fielding
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity.

Authors:  E T Iwamoto
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  The discriminative stimulus properties of barbiturate stereoisomers.

Authors:  W D Wessinger; G R Wenger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline.

Authors:  S G Holtzman; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

6.  Effects of ethylketazocine and morphine alone and in combination with naloxone on schedule-controlled behavior in pigeons.

Authors:  J L Katz
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Comparison of sigma- and kappa-opiate receptor ligands as excitatory amino acid antagonists.

Authors:  S C Berry; S L Dawkins; D Lodge
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

8.  Antagonism of the discriminative effects of ethylketazocine, cyclazocine, and nalorphine in macaques.

Authors:  A M Young; K R Stephens
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.

Authors:  A H Tang; R J Collins
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Psychotomimetic sigma-ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.

Authors:  D K Bartschat; M P Blaustein
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.